LEUKEMIA, LYMPHOCYTYC

Clinical trials for LEUKEMIA, LYMPHOCYTYC explained in plain language.

Never miss a new study

Get alerted when new LEUKEMIA, LYMPHOCYTYC trials appear

Sign up with your email to follow new studies for LEUKEMIA, LYMPHOCYTYC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for elderly CLL patients: targeted drug shows promise

Disease control Ongoing

This study tests a daily pill called PCI-32765 for people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who are over 65 or have a specific genetic change (17p deletion). These groups often don't respond well to standard chemotherapy. The goal is to s…

Matched conditions: LEUKEMIA, LYMPHOCYTYC

Phase: PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control

Last updated May 17, 2026 06:51 UTC

LEUKEMIA, LYMPHOCYTYC

Get alerted when new LEUKEMIA, LYMPHOCYTYC trials appear

New hope for elderly CLL patients: targeted drug shows promise